Supernus Pharmaceuticals(SUPN) - 2025 Q2 - Quarterly Results

Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 22, 2025 Supernus Pharmaceuticals, Inc. (Exact name of registrant as specified in its charter) | Delaware | 001-35518 | 20-2590184 | | --- | --- | --- | | (State or other jurisdiction of incorporation | | (I.R.S. Employer Identification No.) | | or organization) | (Commission File Number) ...